Literature DB >> 12397088

Degradation of cellular mRNA is a general early apoptosis-induced event.

M Julieta Del Prete1, Maria S Robles, Ana Guáo, Carlos Martínez-A, Manuel Izquierdo, Jose A Garcia-Sanz.   

Abstract

The fate of cellular mRNAs was analyzed in several cell lines of lymphoid origin, after induction of apoptosis by different mechanisms. Cytoplasmic mRNAs are specifically degraded as part of the early apoptotic response. This degradation is not species restricted and is independent of the cell line, the apoptotic stimulus, the intrinsic half-life of the mRNAs, and the transcriptional status of the gene (constitutive or inducible). mRNA degradation precedes DNA fragmentation and correlates with the appearance of phosphatidylserine in the outer cell membrane. In addition, apoptosis-induced mRNA degradation is an active process that can be dissected from other apoptotic hallmarks (degradation of annexin V, DNA, and poly(ADP-ribose) polymerase [PARP]), which suggests that apoptosis-induced mRNA degradation is controlled by a distinct signaling pathway. Furthermore, mRNA degradation also occurs in vivo, specifically during thymocyte apoptosis. Taken together, these data support the notion that degradation of mRNA is a general early apoptotic event that may become a new apoptotic hallmark.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12397088     DOI: 10.1096/fj.02-0392fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  24 in total

1.  2'-AMP and 3'-AMP inhibit proliferation of preglomerular vascular smooth muscle cells and glomerular mesangial cells via A2B receptors.

Authors:  Edwin K Jackson; Delbert G Gillespie; Raghvendra K Dubey
Journal:  J Pharmacol Exp Ther       Date:  2011-01-26       Impact factor: 4.030

Review 2.  The 2',3'-cAMP-adenosine pathway.

Authors:  Edwin K Jackson
Journal:  Am J Physiol Renal Physiol       Date:  2011-09-21

3.  DNA methylation screening identifies driver epigenetic events of cancer cell survival.

Authors:  Daniel D De Carvalho; Shikhar Sharma; Jueng Soo You; Sheng-Fang Su; Phillippa C Taberlay; Theresa K Kelly; Xiaojing Yang; Gangning Liang; Peter A Jones
Journal:  Cancer Cell       Date:  2012-05-15       Impact factor: 31.743

4.  Cell Origin Dictates Programming of Resident versus Recruited Macrophages during Acute Lung Injury.

Authors:  Kara J Mould; Lea Barthel; Michael P Mohning; Stacey M Thomas; Alexandra L McCubbrey; Thomas Danhorn; Sonia M Leach; Tasha E Fingerlin; Brian P O'Connor; Julie A Reisz; Angelo D'Alessandro; Donna L Bratton; Claudia V Jakubzick; William J Janssen
Journal:  Am J Respir Cell Mol Biol       Date:  2017-09       Impact factor: 6.914

5.  Cationic liposomal co-delivery of small interfering RNA and a MEK inhibitor for enhanced anticancer efficacy.

Authors:  Seung Hee Kang; Hee-Jeong Cho; Gayong Shim; Sangbin Lee; Su-Hyeon Kim; Han-Gon Choi; Chan-Wha Kim; Yu-Kyoung Oh
Journal:  Pharm Res       Date:  2011-08-31       Impact factor: 4.200

6.  Analysis of the protein expression changes during taxol-induced apoptosis under translation inhibition conditions.

Authors:  David Piñeiro; Víctor M González; Matilde Salinas; M Elena Martín
Journal:  Mol Cell Biochem       Date:  2010-08-19       Impact factor: 3.396

7.  Pelota interacts with HAX1, EIF3G and SRPX and the resulting protein complexes are associated with the actin cytoskeleton.

Authors:  Ozanna Burnicka-Turek; Aleksandra Kata; Byambajav Buyandelger; Linda Ebermann; Nadine Kramann; Peter Burfeind; Sigrid Hoyer-Fender; Wolfgang Engel; Ibrahim M Adham
Journal:  BMC Cell Biol       Date:  2010-04-20       Impact factor: 4.241

8.  Trichostatin A affects the secretion pathways of beta and intestinal endocrine cells.

Authors:  Aubrey R Tiernan; Julie A Champion; Athanassios Sambanis
Journal:  Exp Cell Res       Date:  2014-10-16       Impact factor: 3.905

9.  mRNA-Seq of single prostate cancer circulating tumor cells reveals recapitulation of gene expression and pathways found in prostate cancer.

Authors:  Gordon M Cann; Zulfiqar G Gulzar; Samantha Cooper; Robin Li; Shujun Luo; Mai Tat; Sarah Stuart; Gary Schroth; Sandhya Srinivas; Mostafa Ronaghi; James D Brooks; Amirali H Talasaz
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

10.  Gene expression and pathway analysis of ovarian cancer cells selected for resistance to cisplatin, paclitaxel, or doxorubicin.

Authors:  Cheryl A Sherman-Baust; Kevin G Becker; William H Wood Iii; Yongqing Zhang; Patrice J Morin
Journal:  J Ovarian Res       Date:  2011-12-05       Impact factor: 4.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.